Cantor Fitzgerald Starts Kura Oncology (KURA) at Overweight (CORRECTION)
Tweet Send to a Friend
Cantor Fitzgerald analyst Li Watsek initiated coverage on Kura Oncology (NASDAQ: KURA) with an Overweight rating and $30 price target.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
